SUVRETTA CAPITAL MANAGEMENT, LLC 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:23 pm Purchase | 2023-12-31 | 13G | Kura Oncology, Inc. KURA | SUVRETTA CAPITAL MANAGEMENT, LLC | 7,472,343 9.990% | 1,095,528 (+17.18%) | Filing |
| 2023-02-13 1:07 pm Purchase | 2022-12-31 | 13G | Kura Oncology, Inc. KURA | SUVRETTA CAPITAL MANAGEMENT, LLC | 6,376,815 9.300% | 2,804,396 (+78.50%) | Filing |
| 2022-02-11 4:55 pm Purchase | 2021-12-31 | 13G | Kura Oncology, Inc. KURA | SUVRETTA CAPITAL MANAGEMENT, LLC | 3,572,419 5.400% | 69,000 (+1.97%) | Filing |
| 2021-12-09 4:31 pm Purchase | 2021-11-29 | 13G | Kura Oncology, Inc. KURA | SUVRETTA CAPITAL MANAGEMENT, LLC | 3,503,419 5.300% | 3,503,419 (New Position) | Filing |